Expert panelists review new data on treatment and management of nmCRPC, mHSPC, and mCRPC and consider how these data may impact clinical practice.
EP. 1: Breakthroughs in Imaging Modalities for Prostate CancerMarch 3rd 2023
Five expert panelists in prostate cancer consider how recent advances in imaging, particularly PSMA-PET, have impacted the field, and highlight guidelines that may aid clinicians in selecting amongst the available imaging modalities.
EP. 5: Goals of Treatment for Non-metastatic Castration-Resistant Prostate CancerMarch 29th 2023
Expert oncologists provide a focused review on goals of therapy for patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
EP. 6: nmCRPC: Clinical Trial Data on AR InhibitorsMarch 29th 2023
Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.